These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1606 related items for PubMed ID: 16890600

  • 1. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 2. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 4. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 5. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H.
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [Abstract] [Full Text] [Related]

  • 6. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y, Lang QB, Chen Z, Li B, Yu CQ, Zhu DZ, Huang XQ, Zhai XF, Ling CQ.
    Chin Med J (Engl); 2009 Sep 05; 122(17):1990-5. PubMed ID: 19781383
    [Abstract] [Full Text] [Related]

  • 7. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 05; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 8. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.
    J Hepatol; 2012 Apr 05; 56(4):886-92. PubMed ID: 22173160
    [Abstract] [Full Text] [Related]

  • 9. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
    Guiu B, Colin C, Cercueil JP, Loffroy R, Guiu S, Ferrant E, Jouve JL, Bonnetain F, Boulin M, Ghiringhelli F, Minello A, Hillon P, Bedenne L, Krause D, Chauffert B.
    Am J Clin Oncol; 2009 Jun 05; 32(3):238-44. PubMed ID: 19349854
    [Abstract] [Full Text] [Related]

  • 10. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003 Jun 01; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 13. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M, Liver Cancer Study Group of Japan.
    AJR Am J Roentgenol; 2010 Mar 01; 194(3):830-7. PubMed ID: 20173167
    [Abstract] [Full Text] [Related]

  • 14. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
    O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST.
    Br J Surg; 2003 Mar 01; 90(3):325-31. PubMed ID: 12594668
    [Abstract] [Full Text] [Related]

  • 15. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 16. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2010 Mar 15; 17(3):869-77. PubMed ID: 20033326
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J.
    Hepatology; 2002 May 15; 35(5):1164-71. PubMed ID: 11981766
    [Abstract] [Full Text] [Related]

  • 18. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD, Bleck JS, Dettmer A, Chavan A, Rosenthal H, Merkesdal S, Frericks B, Zender L, Malek NP, Greten TF, Kubicka S, Manns MP, Galanski M.
    Hepatobiliary Pancreat Dis Int; 2007 Jun 15; 6(3):259-66. PubMed ID: 17548248
    [Abstract] [Full Text] [Related]

  • 19. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1291-8. PubMed ID: 19392861
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S.
    Int J Oncol; 2002 Aug 15; 21(2):427-32. PubMed ID: 12118341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.